ArrayExpress Uploader0humanisolated limb infusion w/ melphalannot specifiedstable disease SDisolated limb infusion w/ melphalannot specifiedcomplete response CRisolated limb infusion w/ melphalanBraf-WT Nras-mutantcomplete response CRisolated limb infusion w/ melphalannot specifiednon-evaluable n.e.isolated limb perfusion w/ melphalannot specifiednon-evaluable n.e.isolated limb perfusion w/ melphalanBraf-mutant Nras-WTcomplete response CRisolated limb perfusion w/ melphalannot specifiedprogressive disease PDisolated limb perfusion w/ melphalannot specifiedprogressive disease PDisolated limb perfusion w/ melphalanBraf-mutant Nras-WTprogressive disease PDisolated limb perfusion w/ melphalanBraf-mutant Nras-WTcomplete response CRisolated limb perfusion w/ melphalannot specifiednon-evaluable n.e.isolated limb perfusion w/ melphalannot specifiednon-evaluable n.e.isolated limb perfusion w/ melphalannot specifiednon-evaluable n.e.isolated limb infusion w/ melphalannot specifiednon-evaluable n.e.isolated limb infusion w/ melphalannot specifiedcomplete response CRisolated limb infusion w/ melphalannot specifiedprogressive disease PDisolated limb infusion w/ melphalannot specifiedpartial response PRisolated limb perfusion w/ melphalanBraf-WT Nras-mutantcomplete response CRisolated limb infusion w/ melphalannot specifiedprogressive disease PDisolated limb infusion w/ melphalannot specifiedcomplete response CRisolated limb infusion w/ melphalannot specifiedstable disease SD4350arrayexpress_sid4An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with melphalan in the setting of...E-GEOD-34599/profile/8773/arrayexpressuploader321diseaselimbmelanomaDec.12, 2014Falsein-transit-extremity-melanoma-iiiE-GEOD-34599_A-AFFY-44In-transit extremity melanoma IIISep.17, 2014An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with melphalan in the setting of isolated limb infusion or isolated limb perfusion. Gene expression profiles were obtained from 21 lesions across 19 patients and evaluated for expression that correlated with response to melphalan isolated limb infusion. Chemotherapy response analysis: complete response - CR; partial response - PR; stable disease - SD; progressive disease - PD; not evaluable - n.e.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34599http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-34599/samples/